News Release
More-
March 19, 2024
Notice Concerning Status of Acquisition and Completion of the Company's Own Shares -
March 1, 2024
Notice Concerning Status of Acquisition of the Company's Own Shares -
February 1, 2024
Notice Concerning Status of Acquisition of the Company's Own Shares -
January 4, 2024
Notice Concerning Status of Acquisition of the Company's Own Shares -
December 12, 2023
KORSUVA® IV Injection Syringe for Dialysis 17.5μg, 25.0μg and 35.0μg to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis
Topics
More-
May 7, 2024
Financial Results (May 7, 2024) -
May 7, 2024
R&D Pipeline as of May 2024 -
January 30, 2024
The Third Quarter of FY2023 (January 30, 2024) -
November 6, 2023
The Second Quarter of FY2023 (November 6, 2023) -
October 30, 2023
Annual Report 2023